Spire Healthcare Group (LON:SPI – Get Free Report) issued its earnings results on Wednesday. The company reported GBX (0.50) earnings per share for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a net margin of 1.04% and a return on equity of 2.22%.
Spire Healthcare Group Trading Up 0.2%
Shares of Spire Healthcare Group stock traded up GBX 0.50 during midday trading on Wednesday, reaching GBX 246. 2,911,963 shares of the company’s stock traded hands, compared to its average volume of 5,409,545. The company has a market cap of £985.47 million, a PE ratio of 61.50, a price-to-earnings-growth ratio of 1.06 and a beta of 0.93. The stock has a 50 day moving average of GBX 237.57 and a 200-day moving average of GBX 207.17. Spire Healthcare Group has a 12 month low of GBX 140.80 and a 12 month high of GBX 251.50. The company has a debt-to-equity ratio of 177.14, a quick ratio of 0.73 and a current ratio of 0.63.
Analyst Ratings Changes
Separately, Royal Bank Of Canada lowered Spire Healthcare Group to a “sector perform” rating and reduced their price objective for the stock from GBX 300 to GBX 250 in a research note on Monday, September 7th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Spire Healthcare Group currently has an average rating of “Moderate Buy” and an average price target of GBX 247.50.
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
Featured Stories
- Five stocks we like better than Spire Healthcare Group
- AI Uncertainty Is Rising, But These 3 Chip ETFs Still Have Momentum
- Arhaus Has New Momentum—Could Other Furniture Stocks Be Next?
- Can Boxabl Turn Modular Homes Into AI Data Center Infrastructure?
- Up All Night: How Nasdaq’s 23-Hour Trading Could Wake Up Wall Street
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
